Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion type Assertion NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_head.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion evidence source_evidence_literature NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion SIO_000772 17607666 NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion wasDerivedFrom befree-20140225 NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.
- NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_assertion wasGeneratedBy ECO_0000203 NP234950.RAeMI34Z5ZdqNUtHXDKzQW0onl_I8Ck1BuEqZ4t47G4UE130_provenance.